DPP4 and diabetes mellitus: These bioactive peptides have been shown to have the ability to effectively manage diabetes by inhibiting digestive enzymes, lowering insulin absorption, and blocking dipeptidyl peptidase IV (DPP-IV) activity, among other antidiabetic processes (Table 5d).